Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Incorporating Metagenomic Next-generation Sequencing in the Management of Pneumonia on Diagnostic Efficiency and Outcomes: A Randomized Controlled Trial

NCT05979350 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT05979350
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05979350 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Incorporating Metagenomic Next-generation Sequencing in the Management of Pneumonia on Diagnostic Efficiency and Outcomes: A Randomized Controlled Trial
Lead sponsor
National Taiwan University Hospital
Phase
Not applicable
Overall status
Active, not recruiting
Start date
August 7, 2023
Completion date
November 30, 2025
Enrollment
114 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diagnosis, pneumonia